Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma

B. Muellinger, A. Wenker, D. Koerber, P. Kroneberg, G. Scheuch (Gemuenden, Germany)

Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Session: Recent advances in the treatment and pathogenesis of asthma
Session type: Thematic Poster Session
Number: 3635
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Muellinger, A. Wenker, D. Koerber, P. Kroneberg, G. Scheuch (Gemuenden, Germany). Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma. Eur Respir J 2008; 32: Suppl. 52, 3635

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009

Adherence to inhaled steroids treatment using smart nebulisers in severe asthmatics
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

When to give corticosteroid inhalation therapy in stable COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Improved and maintained asthma control with once-daily budesonide/formoterol single inhaler therapy in mild-to-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001

Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011



Pharmacology of intermittent and continuous inhaled corticosteroid therapy
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013


Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Novel nebulisation of budesonide as add-on treatment in uncontrolled asthmatics
Source: International Congress 2017 – Inhalers and their use
Year: 2017

The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001

An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate-severe persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004

Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010


Adding slow-released theophyllne to inhaled corticosteroids in the treatment of mild persistent asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007